Deschloroetizolam is a short-acting psychoactive substance of the thienodiazepine class which has been shown to produce depressant, anxiolytic, sedative, hypnotic, muscle relaxant, anticonvulsant and amnesic effects. Deschloroetizolam, like benzodiazepines, binds to modulatory sites on the GABA receptors. Deschloroetizolam is closely related to etizolam (Etilaam), triazolam (Halcion), and alprazolam (Xanax). It is not prescribed and is not recognised as a controlled substance in many parts of the world, leading to its appearance within grey market research chemical vendors in 2014.
Deschloroetizolam has a relatively fast onset of action and symptomatic relief. It is half as potent as its parent compound etizolam with a duration which is twice as long. It also has a similar bioavailibility and a similar time to onset in comparison to the parent drug. 2mg of deschloroetizolam is thought to be of similar potency to 10mg of diazepam.
Per NDEWS Web Monitoring Team Report (Nov 2021):
How is it being discussed? Deschloroetizolam is also referred to as “Etizolam-2”. Deschloroetizolam is co-mentioned with other thienotriazolodiazepines and benzodiazepine-derivative drugs on Reddit. Commenters describe the drug’s effects as long-lasting compared to Etizolam.
Drug Terms: Deschloroetizolam, “Etizolam-2”.